Analytical testing also known as the material testing is used expansively to define many processes which need identification of the nature or the chemical makeup of the specific sample. Pharmaceutical analytical testing plays a vital role in the manufacturing of biopharmaceuticals. The biopharm industry makes use of analytical testing to mend productivity, characterization of biosimilars/biologics, optimizing and monitoring processes, and offer control of the real-time product. Therefore, there is a rise in need for the testing of pharmaceutical analytic solutions across the world.
“Pharmaceutical Analytical Testing Market is expected to reach US$ 12,352.35 million by 2030 from US$ 7,137.91 in 2022; it is estimated to grow at a CAGR of 8.2%from 2023 to 2030. The report highlights trends prevailing in the global Pharmaceutical Analytical Testing market, and drivers and hindrances pertaining to the market growth.
Request a Sample Report @ https://www.coherentmarketinsights.com/insight/request-sample/5383
Rise in need for Pharmaceutical Analytical Testing worldwide is anticipated to fuel the market growth of the PAT worldwide in the predicted period. For example, analytical testing is mainly applied in pharmaceutical and biopharmaceutical companies for an application series. Portreet Pharmaceutical in November 2021 introduced a novel label specializing in the analytical testing of small molecule which are active ingredients of pharmaceuticals. The company aims to focus on customers that vary from virtual pharmaceutical companies to new startups of biotechnology. Portreet promises to provide to its clients fast and economical turn-around on testing and development of method together.
Rise in number of drug consents and the clinical trials across the world is anticipated to provide substantial opportunities of growth for the companies in the market of PAT worldwide. Analytical testing is a very important part of the development of the drug and manufacturing, from route designs and optimization by means of clinical trials and finally to the finished product. Development of analytical method and its validation is very vital for any drug development program. As per WHO (World Health Organization), the U.S.A did the most number of trials during the phase 1999-2021 which is 157,618, trailed by China 80,333 and Japan 57,754.
Complicated regulatory structure to maintain the lab and the threat in the growth of appropriate analytical methods are the main factors anticipated to hinder the market growth of the pharmaceutical analytical testing worldwide. For example, every country has their own rules and guidelines in regards to innovation, marketing, testing of drugs, manufacturing, and post marketing studies amongst others. Pre-market approval or consent is a technique of FDA for reviewing scientific and regulatory in order to estimate the safety and efficacy of the devices in the laboratory by the FDA 21 CFR. Therefore, strict rules linked with the pharmaceutical testing are anticipated to hinder the market growth.
The COVID-19 pandemic and outbreak created a positive influence on the market of PAT owing to the rise in development of the novel drugs and vaccines in controlling the virus spread. The pandemic raised the need for analytical testing since this is needed at all the phases of the development of the drug in monitoring safety, security, efficacy and accuracy. As per World Health Organization, April 2022, about 349 vaccines were developed, which consequently raised the need for analytical testing solutions for the vaccines of COVID-19 under medical trials. For example, Eurofins Scientific approved the testing of Ad26.COV2.S, an investigational COVID-19 vaccine candidate by Johnson & Johnson. This will push the market growth.
Globally, the market of pharmaceutical analytical testing was priced at US$ 7137.91 million in the year 2022 and is predicted to the extent of US$ 12352.3 million by the year 2030 at a CAGR of 8.2% from 2023 to 2030
Considering the type of service, the segment of bioanalytical testing holds a dominating place in the market of pharmaceutical analytical testing in 2022, reporting for 32.3% share of value, raising the consent and the introduction of novel products is anticipated to fuel the development of the segment in the predicted period.
Analytical solutions and technologies play a vital part in the manufacturing of biopharmaceutical. Analytical testing is the complicated part of the development of the drug and manufacturing, from route design and optimization through medical trials and to finished products. With the rise in novel drugs development and inventions, and also rise in the medical trials, need for analytical testing is rising at a very fast pace, This tendency is anticipated to last in the predicted period, pushing the market growth.
Limited Period Offer | Report Available Now at UP TO 45% off Discounted Pricing @
Single User License : https://www.coherentmarketinsights.com/promo/buynow/5383
Multi Users License : https://www.coherentmarketinsights.com/promo/buynow/5383
Corporate Users License : https://www.coherentmarketinsights.com/promo/buynow/5383
Note: Special discounted pricing is only applicable for direct purchase through website. In case of customization, discount would be subject to scope and coverage of the report.
The main companies participating in the market of pharmaceutical analytical testing are Steris PLC, West Pharmaceutical Services Inc., Boston Analytical, Intertek Pharmaceutical Services, Pace Analytical Services, Labcorp (Toxikon Inc.), SGS SA, Eurofins Scientific, and Laboratory Testing Inc., among others.
Labcorp in February 2022, declared the inaugural of a novel diagnostics laboratory in South Bend, Indiana, enabling the company to increase service levels and assistances to patients and doctors in South Bend and all over the region.
SGS in October 2021, pronounced that the extension of its bioanalytical laboratory in Poitiers, France is ready, coupled with the novel 800-mt.sq. building to encounter the developing need for bioanalytical testing solutions to upkeep the development of drug worldwide.
SGS SA in December 2021 announced the completion of acquisition of Quay Pharm (Quay Pharmaceuticals Limited) which is a provider of innovative, research on formulation and development solutions for the biopharmaceutical sector worldwide.
Request For Customization at: https://www.coherentmarketinsights.com/insight/request-customization/5383
Table of Contents:
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Service Type
- Market Sanpshot, By Geography
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Growing demand for analytical testing services/solutions
- Challenges in the development of proper analytical techniques
- Government initiatives to strengthen analytical testing capabilities
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER’s Analysis
- Merger and Acquisition Scenario
- Market Dynamics
- Global Pharmaceutical Analytical Testing Market – Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
- Global Pharmaceutical Analytical Testing Market, By Service Type, 2017-2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 – 2028
- Segment Trends
- Bioanalytical Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
- Method Development and Validation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
- Stability Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
- Drug Substances Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
- Other Service Types
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
- Introduction
- Global Pharmaceutical Analytical Testing Market, By Geography, 2017-2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 – 2028
- Segment Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
- Middle East and Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
- Rest of World
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
- Introduction
- Competitive Landscape
- Steris PLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- West Pharmaceutical Services Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Boston Analytical
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Intertek Pharmaceutical Services
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Pace Analytical Services
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Labcorp (Toxikon Inc.)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- SGS SA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Eurofins Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Laboratory Testing Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Analyst Views
- Steris PLC
- Section
- Research Methodology
- About us
Related Reports
Cryopreservation equipment market
About Us:
Coherent Market Insights is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Coherent Market Insights has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We at Coherent are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defence, among different ventures present globally.
Contact Us :
Mr. Shah
Coherent Market Insights
533 Airport Boulevard, Suite 400,
Burlingame, CA 94010, United States.
U.S.A: +1-206-701-6702
UK: +44-020-8133-4027
JAPAN: +050-5539-1737
India: +91-848-285-0837
Email: sales@coherentmarketinsights.com
Website: https://www.coherentmarketinsights.com/